HLA-C and chronic obstructive pulmonary disease: Furthermore, there were no significant underrepresentations (a potentially protective polymorphism) of any HLA-A or HLA-B allele in the COPD, whereas there was a trend for decreased HLA-C*12 prevalence among the pilot trial SC subjects (Supplemental Table 2).